US Stock MarketDetailed Quotes

RLMD Relmada Therapeutics

Watchlist
  • 3.830
  • +0.010+0.26%
Close May 8 16:00 ET
  • 4.250
  • +0.420+10.97%
Post 19:19 ET
115.57MMarket Cap-1167P/E (TTM)

Relmada Therapeutics Key Stats

Relmada Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings Estimates

May 8, 2024

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.86

+1.15%

Buy

Apr 30, 2024

Relmada Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2020/Q3-- / 0.000--
--2020/Q2-- / 0.000--
Mar 19, 20242023/Q40.000 / 0.000--
Nov 8, 20232023/Q30.000 / 0.000--
Aug 8, 20232023/Q20.000 / 0.000--
May 11, 20232023/Q10.000 / 0.000--
Mar 23, 20232022/Q40.000 / 0.000--
Nov 10, 20222022/Q30.000 / 0.000--
Aug 11, 20222022/Q20.000 / 0.000--
May 5, 20222022/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2020/Q3-- / 0.000--
--2020/Q2-- / 0.000--
Mar 19, 20242023/Q40.000 / 0.000--
Nov 8, 20232023/Q30.000 / 0.000--
Aug 8, 20232023/Q20.000 / 0.000--
May 11, 20232023/Q10.000 / 0.000--
Mar 23, 20232022/Q40.000 / 0.000--
Nov 10, 20222022/Q30.000 / 0.000--
Aug 11, 20222022/Q20.000 / 0.000--
May 5, 20222022/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Relmada Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 30, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg